Most Recent
Afterpay can’t block iSignthis from trade marking ‘Clearpay’ for ASX rival
Intellectual Property 2024-03-04 10:13 pm By Cat Fredenburgh

Afterpay has failed to block fintech iSignthis from registering ‘Clearpay’ as a trade mark for its blockchain-based trading system, with an IP Australia delegate finding […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Block’s point-of-sale invention not patentable, IP Australia says
Intellectual Property 2023-08-14 11:20 pm By Cat Fredenburgh

IP Australia has rejected Afterpay owner Block’s bid to patent a method for adjusting animations to enable a large volume of point-of-sale transactions on mobile […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Quorn’s patent application for vegan burger falls apart
Intellectual Property 2023-05-26 11:07 pm By Gareth Baker

Marlow Foods, maker of popular meat-replacement product Quorn, has lost an application to patent a vegan burger that contains a non-egg binding agent, with IP […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Block’s mobile payment method not patentable, says IP Australia
Fintech 2023-05-16 12:14 pm By Sam Matthews

IP Australia has rejected an application by US technology company Block to patent a mobile payment method, saying it does not describe a manner of […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Coca-Cola tastes victory in defence of artificial sweetener patent
Intellectual Property 2021-08-19 9:19 pm By Cindy Cameronne

Intellectual property law firm Spicer Spicer has lost its opposition to Coca-Cola’s patent application for soft drinks and syrups containing an artificial sweetener known as […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Sydney Opera House fights China group’s trade mark
Intellectual Property 2020-12-04 12:45 pm By Miklos Bolza

The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Boehringer scores partial win in challenge to animal vaccine patents
Intellectual Property 2020-08-31 4:45 pm By Alison Eveleigh

German pharmaceutical giant Boehringer has partially succeeded in its opposition to several vaccine patents filed by animal health company Zoetis, used to treat pneumonia in pigs. […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

LG loses challenge to Samsung QLED trade mark
Intellectual Property 2020-07-08 6:36 pm By Miklos Bolza

LG Electronics has lost its opposition to Samsung Electronic’s registration for its ‘Samsung QLED’ trade mark despite IP Australia acknowledging that Samsung’s phones did not […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Broadcaster skewered in battle of the ‘Iron Chef’ trade marks
Intellectual Property 2020-07-06 5:02 pm By Miklos Bolza

The television broadcaster behind the cult cooking show Iron Chef has lost its opposition to an ‘Iron Chef’ trade mark application by an Aussie food […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Regeneron steps up opposition to Kymab’s human rat patent
Intellectual Property 2019-08-26 12:47 pm By Cat Fredenburgh

US biotechnology company Regeneron Pharmaceuticals has filed a Federal Court challenge after losing its opposition to a patent application by UK biopharmaceutical company Kymab for […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.